본문 바로가기
KERD
논문KCI 등재

실험실 종사자에서 실험실 내 바이러스 감염

Viral Infections in Workers in Hospital and Research Laboratory Settings

홍기호
대한임상미생물학회 (Korean Society of Clinical Microbiology)|2017.06|Annals of Clinical Microbiology|제20권 제2호|pp. 27-34

0

조회

0

다운로드

2

인용

0

참고문헌

키워드

Laboratory infectionOccupational diseasesVirus diseases

초록

바이러스는 많은 신종 감염병의 원인이 되므로, 바이러스의 실험실 감염은 앞으로 계속 발생할 것이다. 그러나 실제 발생 현황, 소독제나 예방법에 대한 지식 등 많은 부분이 아직 규명되어야 한다. 생물 안전의 기본 원칙은 다른 미생물과 다르지 않으나, 안전 수칙과 생물안전 프로그램은 불변의 것이 아니며, 바이러스와 제반 사항을 고려하여 유연하게 바뀔 수 있어야 한다. 지금까지 문헌 보고된 다양한 사례를 검토하여 대부분 기본적인 생물 안전을 준수하지 않아 발생한 것을 확인할 수 있었다. [Ann Clin Microbiol 2017;20:27-34]

Abstract

As many emerging human infections are caused by viruses, laboratory-acquired viral infection will become more common. However, additional knowledges is needed, including actual incidence, disinfectant, and prevention. Although the general biosafety principles of viruses do not differ from those of other microorganisms, biosafety guidelines and programs are not immutable and could vary according to virus and laboratory environment. Most laboratory-acquired viral infections reported in the literature were caused by violation of biosafety principles. (Ann Clin Microbiol 2017;20:-34)

참고문헌 (80)

  1. Sulkin SE, "Survey of laboratory-acquired infections", Am J Public Health Nations Health, 41, pp.769~781 (1951)
  2. Sulkin SE, "Laboratory-acquired infections", Bacteriol Rev, 25, pp.203~209 (1961)
  3. Singh K, "Laboratory-acquired infections", Clin Infect Dis, 49, pp.142~147 (2009)
  4. Pedrosa PB, "Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects", Int J Infect Dis, 15, pp.e366~376 (2011)
  5. Coelho AC, "Biological risks and laboratoryacquired infections: a reality that cannot be ignored in health biotechnology", Front Bioeng Biotechnol, 3, pp.56~ (2015)
  6. Khabbaz R, "Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases", pp.158~177 (2015), Elsevier
  7. Wurtz N, "Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories", Eur J Clin Microbiol Infect Dis, 35, pp.1247~1258 (2016)
  8. [URL]
  9. "Risk group database"[URL]
  10. "Pathogen Safety Data Sheets and Risk Assessment"[URL]
  11. Korea Centers for Disease Control and Prevention, "Guideline for Laboratory Biosafety", Korea Centers for Disease Control and Prevention, ~ (2016)
  12. Chosewood LC, "Biosafety in Microbiological and Biomedical Laboratories. 5th ed", Dept. of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institutes of Health, ~ (2009)
  13. World Health Organizaiton, "Laboratory Biosafety Manual. 3rd ed", World Health Organization, ~ (2004)
  14. Lloyd G, "Topley and Wilson's Microbiology and Microbial Infections" (2010), John Wiley and Sons
  15. Rusnak J, "Occupational Health Manual for Laboratory Exposures to Select (BSL-3 & BSL-4) and Other Biological Agents", USAMRIID (U.S. Army Medical Research Institute of Infectious Diseases), ~ (2011)
  16. World Health Organization, "Infection Prevention and Control of epidemic- and Pandemic-prone Acute Respiratory Infections in Health Care, WHO Guidelines", World Health Organization, 14~ (2014)
  17. Gralton J, "Protecting healthcare workers from pandemic influenza: N95 or surgical masks?", Crit Care Med, 38, pp.657~667 (2010)
  18. De Carli G, "The importance of implementing safe sharps practices in the laboratory setting in Europe", Biochem Med (Zagreb), 24, pp.45~56 (2014)
  19. Korea Centers for Disease Control and Prevention, "Safety guidance to highly dangerous pathogens", Korea Centers for Disease Control and Prevention, ~ (2016)
  20. Maillard JY, "Principles and Practice of Disinfection, Preservation, and Sterilization", pp.178~207 (2012), John Wiley & Sons
  21. Maillard JY, "Virus susceptibility to biocides: an understanding", Rev Med Microbiol, 12, pp.63~74 (2001)
  22. Springthorpe VS, "Chemical disinfection of human rotaviruses: efficacy of commerciallyavailable products in suspension tests", J Hyg (Lond), 97, pp.139~161 (1986)
  23. Brown TT Jr, "Laboratory evaluation of selected disinfectants as virucidal agents against porcine parvovirus, pseudorabies virus, and transmissible gastroenteritis virus", Am J Vet Res, 42, pp.1033~1036 (1981)
  24. McDonnell G, "Antiseptics and disinfectants:activity, action, and resistance", Clin Microbiol Rev, 12, pp.147~179 (1999)
  25. Zeiger E, "Genetic toxicity and carcinogenicity studies of glutaraldehyde--a review", Mutat Res, 589, pp.136~151 (2005)
  26. Nuanualsuwan S, "Pretreatment to avoid positive RT-PCR results with inactivated viruses", J Virol Methods, 104, pp.217~225 (2002)
  27. Shin GA, "Reduction of Norwalk virus, poliovirus 1, and bacteriophage MS2 by ozone disinfection of water", Appl Environ Microbiol, 69, pp.3975~3978 (2003)
  28. Resnick L, "Stability and inactivation of HTLV-III", LAV under clinical and laboratory environments, 1986, pp.255, 1887~1891
  29. Taylor GR, "A comparison of the virucidal properties of chlorine, chlorine dioxide, bromine chloride and iodine", J Hyg (Lond), 89, pp.321~328 (1982)
  30. Shirai J, "Effects of chlorine, iodine, and quaternary ammonium compound disinfectants on several exotic disease viruses", J Vet Med Sci, 62, pp.85~92 (2000)
  31. Ito K, "Effect of ethanol on antigenicity of hepatitis B virus envelope proteins", Jpn J Infect Dis, 55, pp.117~121 (2002)
  32. Steinmann J, "Virucidal activity of 2 alcohol-based formulations proposed as hand rubs by the World Health Organization", Am J Infect Control, 38, pp.66~68 (2010)
  33. Kimman TG, "Evidence-based biosafety: a review of the principles and effectiveness of microbiological containment measures", Clin Microbiol Rev, 21, pp.403~425 (2008)
  34. Rusnak JM, "Risk of occupationally acquired illnesses from biological threat agents in unvaccinated laboratory workers", Biosecur Bioterror, 2, pp.281~293 (2004)
  35. MacNeil A, "Risks associated with vaccinia virus in the laboratory", Virology, 385, pp.1~4 (2009)
  36. Petersen BW, "Use of vaccinia virus smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses -recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015", MMWR Morb Mortal Wkly Rep, 65, pp.257~262 (2016)
  37. Wei Q, "Immune control strategies for vaccinia virus-related laboratory-acquired infections", Biomed Environ Sci, 27, pp.142~146 (2014)
  38. Fulginiti VA, "Smallpox vaccination: a review, part II. Adverse events", Clin Infect Dis, 37, pp.251~271 (2003)
  39. Wei Q, "Analysis on status and characteristics of laboratory-acquired vaccinia virus infections cases", Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 27, pp.73~75 (2013)
  40. Hsu CH, "Laboratory-acquired vaccinia virus infection in a recently immunized person--Massachusetts, 2013", MMWR Morb Mortal Wkly Rep, 64, pp.435~438 (2015)
  41. McCollum AM, "Investigation of the first laboratory-acquired human cowpox virus infection in the United States", J Infect Dis, 206, pp.63~68 (2012)
  42. Riyesh T, "Laboratory-acquired buffalopox virus infection, India", Emerg Infect Dis, 20, pp.324~326 (2014)
  43. Centers for Disease Control and Prevention (CDC), "Laboratoryacquired West Nile virus infections--United States, 2002", MMWR Morb Mortal Wkly Rep, 51, pp.1133~1135 (2002)
  44. Venter M, "Transmission of West Nile virus during horse autopsy", Emerg Infect Dis, 16, pp.573~575 (2010)
  45. Desmyter J, "Laboratory rat associated outbreak of haemorrhagic fever with renal syndrome due to Hantaan-like virus in Belgium", Lancet, 2, pp.1445~1448 (1983)
  46. Lloyd G, "HFRS outbreak associated with laboratory rats in UK", Lancet, 1, pp.1175~1176 (1984)
  47. Cho SH, "Laboratory-acquired infections with hantavirus at a research unit of medical school in Seoul, 1996", Korean J Prev Med, 32, pp.269~275 (1999)
  48. Umenai T, "Korean haemorrhagic fever in staff in an animal laboratory", Lancet, 1, pp.1314~1316 (1979)
  49. Kawamata J, "Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan", Lab Anim Sci, 37, pp.431~436 (1987)
  50. Martinez VP, "Person-to-person transmission of Andes virus", Emerg Infect Dis, 11, pp.1848~1853 (2005)
  51. "Guideline for vector-borne disease control (Rodent)" (2016)[URL]
  52. Schmaljohn CS, "Vaccines for hantaviruses: progress and issues", Expert Rev Vaccines, 11, pp.511~513 (2012)
  53. "녹십자 ‘한타박스’ 약효 논란 종결짓나, 헬스코리아. 2015 May 13" (2015)[URL]
  54. 배근량, "Laboratory-acquired dengue virus infection by needlestick injury: a case report, South Korea, 2014", Annals of Occupational and Environmental Medicine, 28(2), pp.1~8 (2016), 대한직업환경의학회[DOI]
  55. Britton S, "Laboratory-acquired dengue virus infection--a case report", PLoS Negl Trop Dis, 5, pp.e1324~ (2011)
  56. Capeding MR, "Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial", Lancet, 384, pp.1358~1365 (2014)
  57. Villar L, "Efficacy of a tetravalent dengue vaccine in children in Latin America", N Engl J Med, 372, pp.113~123 (2015)
  58. Lim PL, "Laboratory-acquired severe acute respiratory syndrome", N Engl J Med, 350, pp.1740~1745 (2004)
  59. de Wit E, "SARS and MERS: recent insights into emerging coronaviruses", Nat Rev Microbiol, 14, pp.523~534 (2016)
  60. Emond RT, "A case of Ebola virus infection", Br Med J, 2, pp.541~544 (1977)
  61. Formenty P, "Human infection due to Ebola virus, subtype Côte d'Ivoire: clinical and biologic presentation", J Infect Dis, 179(Suppl 1), pp.S48~53 (1999)
  62. Kortepeter MG, "Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit", Emerg Infect Dis, 14, pp.881~887 (2008)
  63. "Russian Scientist Dies After Ebola Lab Accident", Science, 304, pp.1225~ (2004)
  64. Borio L, "Hemorrhagic fever viruses as biological weapons: medical and public health management", JAMA, 287, pp.2391~2405 (2002)
  65. Henao-Restrepo AM, "Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, clusterrandomised trial (Ebola Ça Suffit!)", Lancet, 389, pp.505~518 (2017)
  66. Barry M, "Brief report: treatment of a laboratory-acquired Sabiá virus infection", N Engl J Med, 333, pp.294~296 (1995)
  67. Ambrosio A, "Argentine hemorrhagic fever vaccines", Hum Vaccin, 7, pp.694~700 (2011)
  68. Kerber R, "Research efforts to control highly pathogenic arenaviruses: a summary of the progress and gaps", J Clin Virol, 64, pp.120~127 (2015)
  69. Filipe AR, "Laboratory infection with Zika virus after vaccination against yellow fever", Arch Gesamte Virusforsch, 43, pp.315~319 (1973)
  70. Pardi N, "Zika virus protection by a single low-dose nucleosidemodified mRNA vaccination", Nature, 543, pp.248~251 (2017)
  71. Li H, "Pandemic and avian influenza a viruses in humans: epidemiology, virology, clinical characteristics, and treatment strategy", Clin Chest Med, 38, pp.59~70 (2017)
  72. "Diseases Outbreak News (DONs)Human infection with avian influenza A(H7N9) virus – China"[URL]
  73. Wong SS, "Avian influenza virus infections in humans", Chest, 129, pp.156~168 (2006)
  74. Laboratory-Acquired Infections in Belgium (2007-2012) An online survey, "Willemarck N", ~ (2015)
  75. Baz M, "H5N1 vaccines in humans", Virus Res, 178, pp.78~98 (2013)
  76. "Interim Guidance on Influenza Antiviral Chemoprophylaxis of Persons Exposed to Birds with Avian Influenza A Viruses Associated with Severe Human Disease or with the Potential to Cause Severe Human Disease"[URL]
  77. Berríos EP, "Foot and mouth disease in human beings. A human case in Chile", Rev Chilena Infectol, 24, pp.160~163 (2007)
  78. David W, "Foot and mouth disease in human beings", Lancet, 357, pp.1463~ (2001)
  79. Simmons N, "If foot and mouth disease were a disease of human beings", Lancet Infect Dis, 1, pp.75~76 (2001)
  80. "Rapid risk assessment: Transmission of Foot and Mouth disease to humans visiting affected areas"[URL]

관련 논문AI추천

국내 연구원들의 생물안전 개념에 대한 현황김대식, 김미경대한임상검사과학회 · 대한임상검사과학회지2018 · 제50권 제1호대학병원 검사실직원의 감염 및 안전수칙준수에 대한 연구김각현, 송석규, 유기원대한임상검사과학회 · 대한임상검사과학회지1999 · 제31권 제2호국내 임상결핵검사실 생물안전 실태조사김영아, 김창기, 용동은, 이혁민대한진단검사의학회 · Laboratory Medicine Online2017 · 제7권 제4호우리나라 미생물 실험실의 생물안전현황김용익, 김종균, 박기동, 은상준, 이진용, 임정수, 황유성대한예방의학회 · 예방의학회지2005 · 제38권 제4호Guidelines for the Laboratory Diagnosis of Middle East Respiratory Syndrome Coronavirus in Korea기창석, 김미나, 김신영, 김재석, 김정호, 성문우, 성흥섭, 용동은, 이미경, 이혁민, 최종락대한감염학회 · Infection and Chemotherapy2016 · 제48권 제1호Bloodbarne Pathogen에 대한 임상병리사의 예방 행태학적 연구안승일, 이창규, 조경진대한임상검사과학회 · 대한임상검사과학회지1998 · 제30권 제2호

이 간행물의 다른 논문 (3건)

인간거대세포바이러스 DNA 정량 중합효소연쇄반응 검사의 실제김미나, 장정현, 성흥섭, 황상현pp. 21-26한 3차 대학병원의 혈액배양 분석(2006년-2015년)권우재, 서자영, 김경희, 정지훈, 안정열, 박필환, 이환태, 서일혜pp. 35-41임신 여성에서 B군 사슬알균 검사[실시간 중합효소연쇄반응법]의 진단정확성과 검출률: 체계적 문헌고찰과 메타분석박선영, 홍성근, 최원정, 김소영, 김석현pp. 42-51
원문 보기